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ABSTRACT
The AF4/FMR2 proteins AFF1 and AFF4 act as a
scaffold to assemble the Super Elongation Complex
(SEC) that strongly activates transcriptional elonga-
tion of HIV-1 and cellular genes. Although they can
dimerize, it is unclear whether the dimers exist and
function within a SEC in vivo. Furthermore, it is un-
known whether AFF1 and AFF4 function similarly
in mediating SEC-dependent activation of diverse
genes. Providing answers to these questions, our
current study shows that AFF1 and AFF4 reside in
separate SECs that display largely distinct gene tar-
get specificities. While the AFF1-SEC is more potent
in supporting HIV-1 transactivation by the viral Tat
protein, the AFF4-SEC is more important for HSP70
induction upon heat shock. The functional difference
between AFF1 and AFF4 in Tat-transactivation has
been traced to a single amino acid variation between
the two proteins, which causes them to enhance the
affinity of Tat for P-TEFb, a key SEC component,
with different efficiency. Finally, genome-wide anal-
ysis confirms that the genes regulated by AFF1-SEC
and AFF4-SEC are largely non-overlapping and per-
form distinct functions. Thus, the SEC represents a
family of related complexes that exist to increase the
regulatory diversity and gene control options during
transactivation of diverse cellular and viral genes.
INTRODUCTION
The elongation stage of RNA polymerase (Pol) II tran-
scription plays an important role in controlling the expres-
sion of many cellular and viral genes (1). The activation
of Pol II elongation along the integrated HIV-1 proviral
DNAby the viral encoded Tat protein is absolutely essential
for productive HIV-1 infection (2,3). This process has long
been used as a model system for studying the mechanism
and factors that control Pol II elongation. Pioneering stud-
ies demonstrate that Tat transactivates HIV-1 by recruiting
the human Positive Transcription Elongation Factor b (P-
TEFb) to the viral promoter through forming a complex
on the TAR RNA stem-loop structure that is located at
the 5′ end of all nascent viral transcripts (4). Composed
of CDK9 and its regulatory partner cyclin T1 (CycT1) or
T2a/2b, P-TEFb releases Pol II from promoter-proximal
pausing through phosphorylating two negative elongation
factors NELF and DSIF to antagonize their inhibitory ac-
tions (2,3). In addition, P-TEFb also phosphorylates the
carboxy-terminal domain (CTD) of the largest subunit of
Pol II, which in turn promotes co-transcriptional mRNA
processing (1).
Although P-TEFb is necessary for Tat activation of HIV-
1 transcription, it is insufficient to support maximal Tat
function (5,6). Affinity purifications followed by proteomics
have led to the identification of the Super Elongation Com-
plex (SEC), in which P-TEFb is an integral component, as
the native form of human co-factor recruited by Tat to the
viral promoter for full HIV-1 transactivation (7,8). Besides
P-TEFb, the SEC also contains ELL1 or ELL2, a member
of the ELL family of elongation stimulatory factors, which
can directly suppress Pol II pausing and synergize with P-
TEFb to greatly promote Tat-transactivation (7).
Within the SEC, the AF4/FMR2 family proteins AFF1
and AFF4 function as a central scaffold that uses short hy-
drophobic regions distributed along the highly flexible axis
to interact with other subunits and assemble the complete
SEC (9,10). The recently solved crystal structure contain-
ing the CycT1-binding sequence (CBS) of AFF4 in com-
plex with human P-TEFb and HIV-1 Tat has revealed di-
rect contacts between AFF4 and Tat on the surface of
CycT1 (11,12). The highly cooperative nature of the interac-
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tions among these three SEC subunits underlies the AFF4-
mediated increase of the affinity of Tat for P-TEFb.
At about the same time when the SEC was identified as
a specific Tat co-factor, the same complex was also found
to be hijacked by several MLL (mixed lineage leukemia) fu-
sion proteins that are created by chromosomal transloca-
tions to cause aberrant activation of key MLL-target genes
and acute childhood leukemia (13–15). Notably, the SEC
subunits AFF1 and AFF4 are among the most common
translocation partners ofMLL during leukemogenesis (16).
It has been proposed that the oncogenic potential of MLL-
AFF1 and MLL-AFF4 is conferred by their associations
with endogenous active SEC complex through dimerization
mediated by the C-terminal homology domains (CHDs) of
AFF1/4 (15). However, whether in the absence of the fu-
sions to MLL, the dimers formed by native AFF1/4 can
also reside and function within a single SEC complex in vivo
has not been officially examined. Furthermore, despite their
sequence similarity, it remains to be determined whether
AFF1 and AFF4 function similarly in mediating the SEC-
dependent activation of transcription of diverse genes.
The current study seeks to answers these questions, and
our data show that AFF1 and AFF4 reside in separate
SEC complexes that display largely distinct activator/gene-
target specificities. Between the two homologous SEC com-
plexes, the AFF1-SEC is more potent in mediating Tat-
transactivation, whereas the AFF4-SEC is more important
for proper HSP70 induction in response to heat shock.
The functional difference between AFF1 and AFF4 in
supporting Tat-transactivation has been traced to a sin-
gle amino acid variation in the CBS region between the
two AFF proteins, which causes them to enhance the
affinity of Tat for CycT1 with different efficiency. Finally,
genome-wide analysis has also confirmed that the genes
regulated by the AFF1- and AFF4-containing SECs are
largely non-overlapping and participate in distinct biolog-
ical functions/pathways. Together, our data support the
model that the SEC represents a family of related complexes
that exist to increase the regulatory diversity and gene con-
trol options during transcriptional activation of diverse cel-
lular and viral genes.
MATERIALS AND METHODS
Antibodies
Polyclonal antibodies against AFF1 (A302-344A), ELL1
(A301-645A), ELL2 (A302-505A), ENL (A302-268A) and
AF9 (A300-595A) were purchased from Bethyl Laborato-
ries. Anti-AFF4 (ab57077) antibody was purchased from
Abcam. The monoclonal antibodies against Flag (M2)
and HA (3F10) were from Sigma-Aldrich and Roche, re-
spectively. The antibodies against CDK9, LARP7 and
HEXIM1 were generated in our own laboratory and have
been described previously (17,18).
Generation of 293-F9H4 cells that stably express Flag-
tagged CDK9 and inducibly express HA-tagged AFF4
The T-RExTM-293 (Invitrogen)-based cell line that stably
expresses CDK9-F and confers puromycin-resistance ((7),
renamed 293-F9) was used to generate 293-F9H4 stable cell
line. AFF4 cDNA was cloned into pCDNAh/TO vector
with an HA tag at the C-terminus. The expression plas-
mid was stably transfected into 293-F9 cells and selected
with hygromycin for two weeks. Individual cell colonies
were picked and screened for the inducible expression of
AFF4-HA upon doxycycline treatment (1 g/ml) for 48
h. For tandem affinity-purification of the SEC containing
both CDK9-F and AFF4-HA within a single complex, the
procedure described previously (7) was used.
Quantitative PCR
The reactions were performedwithApplied Biosystem 7300
Real-Time PCR System and DyNAmo HS SYBR Green
qPCR reagents according to the manufacturers’ instruc-
tions. PCR primers were designed with Integrated DNA
Technologies’ Primer Quest. The PCR conditions include
an initial denaturing step at 92◦C for 2 min and then 40
(for qRT-PCR) or 50 (for ChIP-PCR) cycles of amplifica-
tion. Each cycle consists of a 92◦C segment of 30 s, a 57◦C
segment of 30 s and then a 68◦C segment of 30 s. For ChIP-
PCR, threshold values (Ct) were calculated and normalized
to the input. For qRT-PCR, the values were normalized to
those of GAPDH to obtain the relative folds of induction.
All reactions were run in triplicates.
Chromatin immunoprecipitation assay
The chromatin immunoprecipitation (ChIP) assay was per-
formed as described (7) with some modifications. Briefly,
HeLa cells were incubated at 42◦C for 2 h for heat-shock
and then cross-linked with 1% formaldehyde for 10 min.
Cross-linking was quenched by the addition of glycine
(0.125 M for 5 min). Fixed cells were collected and re-
suspended in SDS lysis buffer (1% SDS, 10 mM EDTA,
50 mM Tris, pH 8.1) and fragmented using a Covaris-S2
sonicator (Covaris, Inc., Woburn, MA) for a total process-
ing time of 25 min (30 s on and 30 s off). Sonicated lysates
equivalent to 2×106 cells were incubated overnight with 3
g specific antibodies per reaction, and the purified prod-
ucts were analyzed by qPCR.All signals were normalized to
the input DNA, and signals generated by non-specific IgG
in control immunoprecipitations were subtracted from the
signals obtained with specific antibodies.
RNA-seq analysis in AFF1/4 knockdown cells
Total RNA extracted from each knockdown (KD) cells
were depleted of rRNAwith Ribo-zero (Illumina) and con-
verted into multiplexed libraries using mRNA-seq Trueseq
Kit following the manufacturer’s instructions (Illumina).
The libraries were then multiplexed and sequenced on Il-
lumina HiSeq 2000 sequencer. All sequencing reads were
aligned to the human reference genome (UCSC hg19 re-
lease) and RefSeq reference transcriptome (ftp://ftp.ncbi.
nih.gov/refseq) using TopHat version 2.0.11 (19). Cufflinks
version 2.2.1 (20) was used to quantify the mRNA abun-
dance for each gene (Fragments PerKilobase of exonmodel
per Million mapped fragments, referred to as FPKM).
The following non-default options were used with cuf-
flinks: frag-bias-correct and multi-read-correct. RankProd
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(21) was applied to perform differential expression analy-
sis between AFF1/4 KD and GFP KD samples. RNA-seq
data have been deposited at GEO database with the acces-
sion number GSE69021.
Gene ontology enrichment analysis
Gene ontology (GO) enrichment analysis was performed
using DAVID Bioinformatic Resources (22).
Constructing the network
Human functional protein interaction network (23) was
used as a template to construct the sub-networks among
the DEGs induced by AFF1 or AFF4 KD. The net-
work template consists of manually curated interactions
(MSKCC cancer cell map; http://cancer.cellmap.org); NCI-
Nature pathway interaction database (http://pid.nci.nih.
gov); KEGG (24); BioCarta (http://www.biocarta.com/
genes/index.asp); Reactome (25); TRED (26); and PAN-
THER (27), and also predicted interactions derived from
non-curated sources. Structurally dense regions in the net-
works were identified by the Markov Clustering (MCL) al-
gorithm (http://www.micans.org/mcl/) with the granularity
parameter set to 2.0.
RESULTS
AFF1 and AFF4 form hetero- but not homodimers and the
heterodimerization is not required for SEC assembly
We began our investigation by examining the dimer forma-
tion between AFF1 and AFF4 when they are not fused to
MLL. To this end, differentially epitope-tagged AFF1 and
AFF4 were co-expressed in HeLa cells to assess their in-
teraction with oneself and each other. Surprisingly, FLAG-
tagged AFF1 (AFF1-F) co-immunoprecipitated efficiently
with HA-tagged AFF4 (AFF4-HA) but not AFF1-HA
(Figure 1A). Likewise, AFF4-F readily pulled down AFF1-
HA but not AFF4-HA (Figure 1B). Thus, AFF1 andAFF4
formed mostly hetero- but not homodimers between them.
To determine the functional significance of AFF1-AFF4
heterodimerization for the SEC assembly, we performed co-
immunoprecipitation (co-IP) experiments to examine the
abilities of AFF1/4 truncation mutants to interact with
other SEC components as well as their respective het-
erodimerization partners. While full length (FL) AFF1 (aa
1-1210) readily co-precipitated with ELL1, ELL2, ENL,
AF9, CDK9 and its heterodimer partner AFF4, deletion
of the CHD (Caa 903-1210) in AFF1 (AFF1CHD) com-
pletely disrupted the binding to AFF4 but maintained nor-
mal interactions with the other SEC subunits (Figure 1C).
On the other hand, compared to FL AFF1, the isolated
CHD associated with a similar level of AFF4 but showed
drastically reduced binding to the other SEC components.
Nearly identical results were also obtained with the AFF4
truncation mutants (Figure 1D; CHD of AFF4: aa 848-
1167). Together, these results suggest that the AFF1-AFF4
heterodimerization did not play a significant role in the SEC
assembly.
AFF1 and AFF4 reside in separate SECs
Consistent with the above observations, in vitro binding
studies performed in the Roeder laboratory have shown
a mutually exclusive existence of AFF1 and AFF4 in re-
constituted SEC complexes (28). To confirm that those
two proteins also do not exist in a single SEC complex
in vivo, we established an HEK293-based cell line called
293-F9H4 that stably expresses Flag-tagged CDK9 and in-
ducibly expresses HA-tagged AFF4 (Figure 1E) and per-
formed tandem affinity-purification of the SEC that con-
tained both CDK9-F and AFF4-HA within a single com-
plex. The parental HEK293 and its derivative 293-F9 that
only stably expresses CDK9-F were used as controls (Fig-
ure 1E).
Western blotting analysis indicates that after the first
round IP with anti-HA mAb, all the known SEC compo-
nents as well as AFF1 were readily detected in precipitates
derived from nuclear extracts (NEs) of 293-F9H4 but not
293-F9 cells (Figure 1F, lane 4). This result suggests that
the IP was specific, and more importantly, that AFF4-HA
became efficiently incorporated into both the SEC and the
AFF1-AFF4 heterodimer in vivo. However, after the sec-
ond round IP with anti-Flag mAb, which precipitated all
the factors present in the same complex with both CDK9-F
and AFF4-HA, only AFF4 and the signature SEC subunits
ELL1, ELL2, ENL, AF9, CycT1 and CDK9 but not AFF1
were detected in the precipitates (lane 6). The same conclu-
sion was also reached when we reversed the order of the
tandem affinity-purification by first performing anti-Flag
and then anti-HA IP in NE of 293-F9H4 and 293-F9 cells
(Figure 1G). The absence of AFF1 in the tandem affinity-
purified AFF4-containing SEC under both conditions in-
dicates that AFF1 and AFF4 resided in separate SECs and
that the AFF1-AFF4 heterodimer existed mostly outside of
an SEC.
AFF1 is more potent than AFF4 in supporting Tat-dependent
HIV-1 transcription
As functional redundancy is often found among homolo-
gous proteins, we next askedwhether theAFF1- andAFF4-
containing SECs display similar or different functions in
mediating transcription. Because the activation of HIV-
1 transcription by Tat has been demonstrated as strongly
SEC-dependent (5,7), we first compared the effects of the
AFF1- and AFF4-SEC on Tat activation of luciferase ex-
pression from the integrated HIV-1 LTR in the HeLa-based
NH1 cells (29). Data in Figure 2A indicate that although
the ectopically expressed AFF1 and AFF4 were both able
to enhance the Tat-activated as well as basal HIV-1 LTR
activity, they did it with different efficiency. When normal-
ized for expression level, AFF1 displayedmarkedly stronger
ability to promote Tat-dependent HIV-1 transcription than
did AFF4 on a per-molecule basis. As for the stimulation
of basal HIV transcription, however, AFF4 was slightly
more active than AFF1 (4.1- versus 3.2-fold, Figure 2A).
In addition to NH1 cells, the impact of AFF1/4 ectopic
expression on HIV-1 transcription was also determined in
Jurkat-based J-Lat A2 cells, which contains an integrated
5′ LTR-Tat-IRES-EGFP-3′ LTR cassette and is a popu-
lar model for studying post-integrative HIV latency (30).
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Figure 1. AFF1 and AFF4 reside in different SECs. (A,B) Nuclear extracts (NEs) derived from HeLa cells co-transfected with the indicated cDNA
constructs were subject to anti-Flag immunoprecipitation (IP). The precipitates andNEswere examined bywestern blotting (WB) for the indicated proteins.
(C,D) HeLa cells were transfected with plasmid vectors expressing the indicated Flag-tagged WT AFF1 (C), AFF4 (D) or their mutant derivatives. Anti-
Flag immunoprecipitates from NE were analyzed by WB for the various proteins as marked on the left, with the star (*) in C denotes the position of
two minor truncated AFF1 bands. (E) Whole cell extracts of the indicated HEK293-based cell lines were analyzed by WB. Both 293-F9 and 293-F9H4
stably expressed CDK9-F, while the latter also expressed AFF4-HA upon induction by doxycycline (Dox). (F,G) CDK9-F, AFF4-HA and their associated
factors were isolated through sequential immunoprecipitations (anti-HA and then anti-Flag in F; anti-Flag and then anti-HA inG) fromNEs of 293-F9H4
cells upon induction of AFF4-HA expression. The immunoprecipitates were analyzed by WB for the proteins indicated. NEs of 293-F9 cells were used in
parallel procedures as controls.
Again, AFF1 was found to stimulate the Tat-dependent
HIV-1 LTR-driven GFP expression much more efficiently
than did AFF4 in this system (Figure 2B).
To investigate the roles of the AFF1- and AFF4-SEC in
HIV-1 transcription from a different angle, we employed
short hairpin (sh)RNAs to KD AFF1/4’s expression and
examined the impact on JQ1 activation of HIV-1 latency
in 2D10 cells, another well-studied latency model created
in Jurkat T cells (31). Recent data indicate that BRD4 acts
as a direct competitor of HIV-1 Tat for binding to the P-
TEFb component of the SEC (29,32–34) and that the BET
bromodomain inhibitor JQ1 antagonizes BRD4’s inhibitive
effect to activate latent HIV (29,35).
In 2D10 cells expressing target-specific shRNAs, analysis
by qRT-PCR reveals that the KD efficiency was very simi-
lar between AFF1 and AFF4 (Figure 2C, right panel). Un-
der such conditions, the activation of the LTR-driven GFP
expression by JQ1 was significantly reduced in the AFF1
KD cells but only weakly diminished in the AFF4 KD cells
(Figure 2C, left panel). Together, these results support the
notion that the AFF1-SEC is more potent than the AFF4-
SEC in supporting Tat-dependent HIV-1 transcription and
latency activation.
AFF1 increases the affinity of Tat for P-TEFb more potently
than does AFF4
What could be the molecular basis underlying the func-
tional difference between AFF1 and AFF4 in their sup-
port of Tat-transactivation? Recent structural studies in-
dicate that AFF4 promotes the Tat-CycT1 interaction by
creating a deeper Tat-binding pocket than that formed by
CycT1 alone (11). In light of this revelation, we decided to
investigate whether AFF1 may behave differently in this re-
5872 Nucleic Acids Research, 2015, Vol. 43, No. 12
Figure 2. AFF1 supports Tat-dependent HIV-1 transcription more efficiently and increases the affinity of Tat for P-TEFb more potently than does AFF4.
(A) Luciferase activities were measured in extracts of NH1 cells containing the integrated HIV-1 LTR-luciferase reporter gene and transfected with the
Tat-HA- and/or AFF1/4-F-expressing construct as labeled. The activity in cells transfected with only the empty vectors was artificially set to 1. The error
bars represent mean ± SD from three independent measurements. The cellular AFF1/4-F levels were determined by anti-Flag western blotting (WB). (B)
J-Lat A2 cells were nucleofected with the AFF1/4-F-expressing construct as labeled. The induction of GFP expression was measured by flow cytometry
and expressed as percentages of GFP(+) cells of the entire population. Cellular AFF1/4-F levels were detected as in A. (C) Top panel: 2D10 cells were
nucleofected with plasmids expressing a non-targeting shRNA (NT) or a specific shRNA targeting AFF1 or AFF4. The activation of the HIV-1 LTR-
driven GFP expression was analyzed as in B. Bottom panel: the knockdown efficiency of the shRNAs was determined by qRT-PCR, with the mRNA ratios
of AFF1/4 over GAPDH displayed. (D) Nuclear extracts (NEs) from HeLa cells co-transfected with the indicated expression constructs were subjected to
anti-Flag immunoprecipitation (IP). The precipitates and NEs were analyzed by WB. (E) Luciferase activities expressed from the integrated HIV-1 LTR
in NH1 cells that were transfected with the Tat (C22G)- and/or AFF1/4-HA-expressing construct were measured and analyzed as in A.
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gard, which can potentially explain the functional difference
between the two AFF proteins.
To determine the impact of AFF1/4 on Tat-P-TEFb in-
teraction, we used the C22G mutant Tat, which lacks an
essential Cys-zinc bridge required for proper folding and is
thus highly sensitive to the AFF-mediated increase in affin-
ity for P-TEFb (5), in the binding assay. While the intro-
duction of increasing amounts of AFF1 into cells allowed
Tat(C22G)-F to pull down more CDK9 and CycT1 in a
dosage-dependent manner (Figure 2D, compare lanes 3 & 4
with 1 & 2), introduction of comparable amounts of AFF4
produced a significantly smaller effect (lanes 5 & 6).
Consistent with their different abilities to promote the
Tat-P-TEFb interaction, AFF1 turned Tat(C22G) into a
powerful activator of theHIV-1 LTR (from 2.0- to 104-fold)
when the two were expressed together (Figure 2E). In com-
parison, the co-expression with AFF4 caused Tat(C22G) to
produce a smaller effect (65-fold). Taken together, these re-
sults support the notion that AFF1 enhances the affinity of
Tat for CycT1 more effectively than does AFF4, which in
turn allows AFF1 to promote Tat activation of HIV tran-
scription with greater efficiency.
Reciprocal exchange of amino acids at a homologous position
alters the abilities of AFF1 and AFF4 to promote Tat binding
to P-TEFb and activation of HIV-1 transcription
The recently solved crystal structure of P-TEFb in complex
with Tat and AFF4 reveals that the AFF4 N-terminal re-
gion, which harbors the CBS (5), also makes multiple direct
contacts with Tat on the surface of CycT1 (11). This obser-
vation prompted us to investigate whether sequence varia-
tions within the CBS of AFF1 and AFF4 could be respon-
sible for the observed functional difference of the two pro-
teins toward Tat. Notably, among the AFF4 residues that
contact Tat, the structure points to M62 and F65 as par-
ticularly important (11). Since phenylalanine occupies an
invariant position at 65 in AFF4 and 70 in AFF1, we fo-
cused our attention onM62 in AFF4 and its corresponding
V67 in AFF1 (Figure 3A) and investigated whether this sin-
gle amino acid difference could explain the different abili-
ties of AFF1 and AFF4 in promoting Tat interaction with
P-TEFb and activation of HIV-1 transcription.
To this end, we introduced the V67M point mutation in
AFF1 andM62Vmutation inAFF4 so that the amino acids
at the corresponding positions in these two proteins were
swapped reciprocally. Although AFF1 V67M was able to
pull down CDK9, CycT1 and other SEC components as
efficiently as WT AFF1 during immunoprecipitation (Fig-
ure 3B), it largely lost the ability to promote the interac-
tion between Tat(C22G) and P-TEFb (Figure 3C). In com-
parison, AFF4 M62V, whose CBS more closely approxi-
mates that of AFF1 after the swap, gained the ability to en-
hance the Tat(C22G)-P-TEFb interaction (Figure 3E), al-
though its interactions with the SEC components were es-
sentially the same as those displayed by WT AFF4 (Fig-
ure 3D). In complete agreement with these binding results,
AFF1 V67M also displayed significantly diminished ability
to support the activation of HIV-1 LTR by Tat(C22G) com-
pared to WT AFF1 (Figure 3F). In contrast, AFF4 M62V
was more active than its WT counterpart in the same assay.
In Figure 3C and E, the levels of full-length AFF1, AFF4
and their point mutants in the Tat(C22G) immunoprecipi-
tates were too low to be detected by western blotting. To
solve this problem, we substituted full-length AFF1/4 with
their respective N-terminal fragments (AFF1 aa 1-308 and
AFF4 aa 1-300) containing the CBS in the binding assays.
Comparing to the full-length proteins, these fragments were
found to accumulate to a higher level, making their detec-
tion in the immunoprecipitates much easier. The data in
Supplemental Figure S1 show that the AFF1/4 N-terminal
fragments and their pointmutants behaved exactly the same
as their full-length counterparts in affecting the binding of
Tat(C22G) to P-TEFb, confirming that the different abil-
ities of AFF1/4 and their mutants to influence the Tat-P-
TEFb interaction lie in their distinct N-terminal CBS re-
gions. More importantly, the relative abundance of the WT
and mutant AFF1/4 fragments that were co-precipitated
with Tat(C22G) correlated precisely with that of P-TEFb
bound to Tat(C22G). Thus, the two point mutations in the
CBS (V67M in AFF1 and M62V in AFF4) affected the in-
teractions of Tat with not only P-TEFb but also AFF1/4.
To better understand why a valine at position 67 in AFF1
and 62 in AFF4 was more beneficial than a methionine for
AFF to promote Tat binding to P-TEFb, we compared the
X-ray structure of Tat-AFF4-P-TEFb with a model where
the AFF4 M62 was replaced by valine (Figure 3G). While
the bulkier M62 in WT AFF4 appears to directly contact
the adjacent Tat K28 residue, which is acetylated in vivo to
enhance Tat binding to P-TEFb/TAR during HIV transac-
tivation (36), the valine substitution at this position would
create a more spacious binding pocket.
Molecular dynamics simulations of the Tat-AFF4-P-
TEFb complex show the flexible Tat K28 side-chain inter-
acting with the backbone of AFF4 as well as the Tat/TAR
recognition motif (TRM) of CycT1 (M. Jacobson, personal
communications). The M62V mutation in AFF4 changes
the equilibrium of these interactions. In particular, K28 hy-
drogen bonds more frequently with the carbonyl oxygen
of AFF4 E61 and has fewer interactions with the CycT1
TRM, allowing the TRM and especially the tryptophan
side-chain in the TRM to adopt different conformations.
Several residues in the TRM, including W258, are known
to be critical for TAR interactions (37). This change in the
interaction network of K28 is likely the cause for increased
affinity of Tat for AFF4M62V-P-TEFb and enhanced Tat-
transactivation by AFF4 M62V.
AFF1 facilitates Tat extraction of P-TEFb from 7SK snRNP
more efficiently than does AFF4
In addition to residing in the SEC, our recent data indicate
that AFF1 also associates with the 7SK snRNP through
binding to CycT1 and that the AFF1-containing subpop-
ulation of 7SK snRNP is preferentially targeted by Tat to
extract P-TEFb owing to AFF1’s facilitation of this pro-
cess (5). In light of these observations and also the above
demonstrations that AFF1 was more effective than AFF4
in enhancing the Tat-CycT1 interaction, we compared the
abilities of the two AFF proteins to interact with the 7SK
snRNP and assist Tat to extract P-TEFb from this complex.
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Figure 3. A single amino acid variation betweenAFF1 andAFF4 is responsible for their different abilities to promote Tat binding to P-TEFb and activation
of HIV-1 transcription. (A) Alignment of homologous sequences encompassing the minimal CycT1-binding sequence (CBS) of AFF1 andAFF4. The dark
shaded blocks indicate amino acids that are identical in the two sequences. The red box contains the residues that are believed to directly contact Tat K28.
The numbers above and below the sequences denote the amino acid positions in the two AFF proeins. (B–E) Nuclear extracts (NEs) of HeLa cells co-
transfected with the indicated expression constructs and anti-Flag immunoprecipitates (IP) derived from the NEs were examined by western blotting
(WB) for the presence of the indicated proteins. (F) Luciferase activities were measured in extracts of NH1 cells containing the integrated HIV-1 LTR-
luciferase reporter gene and expressing the indicated proteins. The activity in cells containing only the empty vectors was artificially set to 1. The error bars
represent mean ± SD from three independent measurements. The cellular levels of AFF1/4-HA proteins were detected by anti-HAWB. (G) Top: surface
representation of Tat (red)-AFF4 (blue)-CycT1 (yellow) interactions centered around Tat K28 as revealed by X-ray crystallography. K28 is forming close
interactions with M62 located in WT AFF4. Bottom: model of the same structure containing the M62V point mutation in AFF4 shows a larger pocket
around Tat K28 that may better accommodate the acetylated K28 side chain.
Toward this goal, we expressed AFF1-F and AFF4-F at
a similar level and performed a co-IP experiment to exam-
ine their interactions with components of the 7SK snRNP
and SEC (Figure 4A). While the two proteins precipitated
similar levels of the SEC subunits ELL2, ENL and AF9,
AFF1-F pulled down more HEXIM1 and LARP7, the two
signature 7SK snRNP components, than did AFF4-F (Fig-
ure 4A). On the other hand, although the co-expression of
Tat with either AFF1 or AFF4 enhanced the disruption of
7SK snRNPmore than did Tat alone as indicated by the dis-
sociation of HEXIM1 from immunoprecipitated CDK9-F
(Figure 4B, compare lane 3 with lanes 4 & 5), AFF1 was
found to be more effective than AFF4 in performing this
task (lanes 4& 5). This is likely due toAFF1’s stronger bind-
ing to 7SK snRNP and better accommodation of Tat than
those of AFF4. Taken all these together, our data indicate
that through increasing the Tat-CycT1 interaction in both
the 7SK snRNP and SEC, AFF1 is a better Tat cofactor
than AFF4 in promoting Tat extraction of P-TEFb from
Nucleic Acids Research, 2015, Vol. 43, No. 12 5875
Figure 4. AFF1 facilitates Tat extraction of P-TEFb from 7SK snRNP more efficiently than does AFF4. (A,B) Nuclear extracts (NEs) prepared from
HeLa cells that were transfected with the indicated expression constructs were subjected to anti-Flag immunoprecipitation (IP). The precipitates and NEs
were examined by western blotting (WB) for the various proteins marked on the left.
7SK snRNP and activation of SEC-dependent HIV-1 tran-
scription.
AFF4- but not AFF1-containing SEC is preferentially used
for heat shock-induced HSP70 expression
The data above indicate that AFF1 and AFF4 are differ-
entially used during Tat activation of HIV-1 transcription.
Together with the evidence that the two proteins exist in sep-
arate SECs, we hypothesized that the AFF1- and AFF4-
SEC can have different gene target specificities. To further
test this idea, we investigated the involvement of AFF1 and
AFF4 during heat shock induction of HSP70 gene expres-
sion, which is another well-characterized model for study-
ing elongation control besides the HIV-1 Tat system (1,38).
First, the dependence on a SEC for proper induction
of HSP70 was examined in HeLa cells that overexpressed
the AFF1 N-terminal 308 amino acids (aa) harboring the
CBS. When expressed in trans, the CBS has been shown
to dominant-negatively inhibit the SEC-dependent Tat-
transactivation by preventing the full-length AFF1/4 from
binding to CycT1 and recruiting ELL1/2 and ENL/AF9
into the complete SEC (5). Similar to the Tat situation,
the expression of WT CBS, but not the CBS mutant
M60A/L61A that fails to bind to CycT1 (5), compromised
the heat shock-induced HSP70 mRNA production (Fig-
ure 5A), confirming that the SEC plays a major role in this
process.
To determine the dependence on the AFF1- and AFF4-
SEC for HSP70 induction, specific shRNAs (shAFF1 and
shAFF4) were expressed separately in HeLa cells to knock
down the expression of the two AFF proteins (Figure 5B,
bottom panel). Examination by qRT-PCR indicates that
the depletion of AFF4, but not AFF1, mitigated the heat
shock-induced HSP70 expression (Figure 5B, top panel).
The decreased HSP70 induction was not the result of an
off-target effect of the shRNA as the reintroduction of a
shAFF4-resistant version of cDNA expressing WT AFF4
into the KD cells rescued the heat shock-induced HSP70
expression (Figure 5C). Further analysis by ChIP indicates
that heat shock increased the association of AFF4 but not
AFF1 to the two 5′ positions (A&B)within theHSP70 gene
locus (Figure 5D). Collectively, these data demonstrate that
between the two homologous SEC complexes, the AFF4-
SEC was more important for proper HSP70 induction in
response to heat shock, whereas the AFF1-SEC was more
potent in mediating Tat-transactivation.
Genes regulated by AFF1- and AFF4-containing SECs are
largely non-overlapping
To determine how the AFF1- andAFF4-SECmay function
in a gene/activator-specificmanner on a genome-wide scale,
we expressed shAFF1 or shAFF4 in HeLa cells and per-
formedRNA-seq to determine the downstream target genes
regulated by the two types of SEC. The efficiency of KD as
determined by qRT-PCR was high, with ∼80% of AFF1
and ∼90% of AFF4 depleted, respectively (Figure 6A).
RNAs purified from the AFF1, AFF4 or the control GFP
KD cells were prepared for single-end, high-throughput se-
quencing. The differentially expressed genes (DEGs) in re-
sponse to AFF1 or AFF4 KDwere identified by RankProd
(P-value≤ 0.05) (21). In total, 1517 and 1602 geneswere dif-
ferentially expressed in response to AFF1 and AFF4 KD,
respectively (Figure 6B). Importantly, the majority of them
(61.8% of the AFF1 KD- and 63.9% of the AFF4 KD-
induced DEGs) were only responsive to AFF1 or AFF4
depletion, suggesting that to a large extent the AFF1- and
AFF4-SEC control distinct subsets of target genes in vivo.
When the GO terms (39) of the DEGs were analyzed, we
found that the DEGs in AFF4 KD cells were markedly en-
riched in cancer-related functions including cell adhesion,
angiogenesis and cell death, whereas the DEGs in response
to AFF1 KD were enriched in terms associated with regu-
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Figure 5. TheAFF4-containing SEC is preferentially used during heat shock induction of HSP70 expression. (A) HeLa cells were transfected with either an
empty (-) or the WT or mutant (M60A/L61A) CBS-expressing vector. Total RNAs isolated from either non-heat shocked (37◦C) and heat shocked (42◦C
for 2 h) cells were subjected to qRT-PCR analysis to determine the levels of HSP70 mRNA relative to those of GAPDH, which was used as an internal
control. The level in non-heat shocked cells transfected with an empty vector was set to 1, and the error bars represent mean ± SD from three independent
measurements. The levels of WT and mutant CBS and endogenous -tubulin were determined by western blotting (WB). (B) Heat shock-induced HSP70
mRNA production in cells expressing the indicated shRNAs was measured as in A. The levels of AFF1 and AFF4 in the KD cells were determined byWB,
with the star (*) denotes the position of a non-specific band. (C) Heat shock-induced HSP70 mRNA production in cells expressing the indicated shRNAs
and a shAFF4-resistent version of wild-type AFF4 (AFF4-SR) was measured as in A. The AFF4 and -tubulin levels in transfected cells were determined
byWB. (D) Top: genomic structure of the HSP70 locus. TSS: transcription start site. The small horizontal bars mark the positions of 2 amplicons generated
by qPCR analysis of the ChIP DNA. Bottom: control or heat-treated HeLa cells were subjected to ChIP-qPCR analysis to determine the levels of AFF4
and AFF1 bound to the HSP70 locus. The signals were normalized to those of input; and the error bars represent mean ± SD from three independent
experiments.
Nucleic Acids Research, 2015, Vol. 43, No. 12 5877
Figure 6. Genes regulated by AFF1- and AFF4-containing SECs are largely non-overlapping. (A) Total RNAs isolated from HeLa cells expressing the
indicated shRNAswere analyzed by qRT-PCR to determine the levels of AFF1 (left) andAFF4 (right) mRNA relative to those ofGAPDH,whichwas used
as an internal control. (B) RNAs purified from the AFF1, AFF4 or the control GFPKD cells were analyzed by RNA-seq, and the numbers of differentially
expressed genes (DEGs) in response to AFF1 or AFF4 KD were identified by RankProd (P-value ≤ 0.05) and displayed in the Venn diagram. (C) Gene
ontology (GO) enrichment analysis of the AFF1 KD- or AFF4 KD-induced DEGs was performed using DAVID. Only the top four gene sets of the AFF
KD DEGs and top five gene sets of the AFF4 KD DEGs are shown. (D,E) The AFF1 KD- (D) and AFF4 KD-induced DEGs (E) were mapped to a
curated human functional protein interaction network and representative modules are shown. Red: genes whose expression was up-regulated by the KD;
Green: genes down-regulated by KD.
lation of steroid hormone response and cellular metabolic
process (Figure 6C). However, both the AFF1 and AFF4
KD also caused differential expression of genes involved in
inflammatory response and nucleosome assembly, suggest-
ing that these genes are jointly regulated by the AFF1- and
AFF4-SEC.
We nextmapped theAFF1/4KD-inducedDEGs to a cu-
rated human functional protein interaction network to fur-
ther study their relationships (23). The resulting AFF1 and
AFF4 KD networks were highly modular, with the genes
in similar pathways clustered together (Figure 6D and E).
The genes that respond to either AFF1 or AFF4 KD share
some network modules such as the G-protein coupled re-
ceptor protein signaling pathway and cell adhesion. How-
ever, many others fall into distinct, non-overlapping net-
work modules including the ones for controlling cytokine
receptor activity and cardiomyopathy in the AFF1KD net-
work (Figure 6D) and the ones involved the JAK-STAT cas-
cade, protein amino acid phosphorylation, and antigen pro-
cessing and presentation in the AFF4 KD network (Figure
6E).
DISCUSSION
AFF1 and AFF4 have been proposed to exist as a dimer
within a single multi-subunit SEC complex based on the
observation that the two AFF proteins can pull down each
other and also a complete set of the remaining SEC sub-
units (15,16). Although the heterodimer formation between
AFF1 and AFF4 is well supported by this observation,
the data presented therein cannot rule out the possibility
that the dimer may in fact exist as a separate entity outside
of a SEC complex. Indeed, by using the tandem affinity-
purification approach described in Figure 1, we show in
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the current study that the AFF1-AFF4 heterodimer is not
required for SEC formation and resides mostly outside of
the SEC in vivo. Thus, an SEC can contain either AFF1 or
AFF4 as its central scaffold but likely not both at the same
time. This conclusion, which was obtained in engineered
HEK293 cells in vivo, is consistent with the observations
made in vitro demonstrating a mutually exclusive existence
of AFF1 and AFF4 in reconstituted SEC complexes (28).
Previously, we have reported that the highly homologous
ENL and AF9 proteins also exist in separate SECs (9). Fur-
thermore, there is no evidence indicating that the homolo-
gous ELL1, ELL2 andELL3 can ever formdimers (16), and
thus they most likely reside in different SECs as well. No-
tably, ELL1 has also been found as a component of the so-
called Little Elongation Complex that is involved in small
nuclear RNA (snRNA) gene expression (40), while ELL3
appears to be specifically selected to prime gene expression
by marking enhancers in ES cells (41). Finally, CycT1 and
its close homologues CycT2a and T2b are also not known
to exist in a single high-order complex. Together, these ob-
servations strongly support the notion that the SEC is in
fact a large family of closely related complexes made possi-
ble by different combinations among groups of homologous
proteins that are all bona fide SEC subunits but do not ex-
ist in a single mega complex all at once. This arrangement
has the benefit of using a relatively small number of individ-
ual components to create a much bigger collection of func-
tional assemblies, which in turn can significantly increase
the regulatory diversity and gene-control options during
SEC-mediated activation of transcription of diverse genes.
In support of the idea that members of the SEC fam-
ily of complexes can have gene/activator-specific functions,
our current study shows that HIV Tat strongly prefers the
AFF1-SEC over the AFF4-SEC in activation of viral tran-
scription. The preference has been traced to a single amino
acid difference located within the N-terminal CBS region
between the two AFF proteins. The crystal structure shows
that AFF4 residue 62 is at the nexus of the interactions be-
tween AFF4, Tat and CycT1 (11). Replacing the bulky me-
thionine at this position with the smaller valine results in
a larger binding pocket for Tat K28, an amino acid that
is strictly conserved and exquisitely regulated by reversible
acetylation during Tat-transactivation (3,36). Molecular
modeling showed that the interaction network of Tat K28
is different within the Tat-AFF4-P-TEFb complex upon
the M62V mutation, with K28 making tighter interactions
with the AFF4 backbone and fewer interactions with the
CycT1 TRM. These changes provide a likely explanation
for the increased affinity of Tat for AFF4 M62V-P-TEFb
(Figure 3E and Supplemental Figure S1) and enhanced Tat-
transactivation by the M62V mutant AFF4 compared to
theWT protein (Figure 3E). Unlike AFF4, AFF1 naturally
has a valine at the corresponding position, which explains
why AFF1 was found to increase the Tat-CycT1 interaction
more effectively than did AFF4 (Figure 2D).
We have previously shown that ELL2 is strongly pre-
ferred over ELL1 as a key SEC subunit to support effi-
cient Tat-transactivation (7), although the molecular basis
of this preference is still unknown. Between the homolo-
gous ENL and AF9 pair, the SECs containing the latter
protein were found to be about 45% more active in mediat-
ing Tat-activated HIV transcription (9). Finally, among the
SEC subunits CycT1, CycT2a and CycT2b, CycT1 is the
only one that is capable of supporting Tat-transactivation
due to its unique TRM that is essential for establishing a
stable Tat-P-TEFb/SEC complex on HIV TARRNA (2,3).
It is therefore highly likely that among all the members of
the SEC family, Tat specifically selects the ones containing
AFF1, ELL2, CycT1 and AF9 for maximal activation of
HIV-1 transcriptional elongation.
In addition to AFF1 and AFF4, the other two
AF4/FMR2 family members, AFF2 and AFF3, have also
been shown to exist in SEC-like complexes termed SEC-L2
and SEC-L3, respectively (42). Although SECs and SEC-
L2 and -L3 have similar kinase activities toward the Pol II
CTD, genome-wide analysis suggests that these complexes
regulate different subsets of genes in cells (42). Importantly,
the current study has extended this notion to even mem-
bers within the SEC family by showing that the AFF1-
SEC and AFF4-SEC can also have different gene target
specificities on a global scale. While our analyses have re-
vealed the molecular basis underlying this difference in the
case of Tat-transactivation, little is known about how other
activators/genes select one type of SEC over others for their
proper transactivation. For example, during heat shock re-
sponse, it is unclear how the AFF4-SEC becomes specifi-
cally selected to bind to the HSP70 gene promoter for in-
duction of expression (Figure 5D) and whether the HSF
transcription factors (38) may play a key role in this process.
Future studies are necessary to answer these questions and
elucidate the molecular mechanism used by cells to differ-
entially use members of the SEC family to not only achieve
gene target specificity but also enhance regulatory diversity
during transcriptional activation of diverse genes.
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